Skip to main content

FDA recall, , Moderate risk

Amgen Corlanor and Sensipar Tablets

Corlanor (ivabradine) tablets contain a foreign substance, and Sensipar (cinacalcet) Tablets have CGMP deviations.

What happened

Amgen, Inc. of Thousand Oaks, California began a recall on June 4, 2026, for Corlanor (ivabradine) tablets due to the presence of a foreign substance, and for Sensipar (cinacalcet) Tablets due to CGMP deviations. The recall was added to the FDA's Enforcement Report and classified on June 23, 2026, with distribution nationwide within the United States. The affected products include Corlanor tablets in 7.5mg and 5mg strengths, and Sensipar tablets in 30mg, 60mg, and 90mg strengths.

What to do

We don't have product-specific instructions for this recall. FDA's general advice for medicine recalls:

  1. Check the FDA or company notice for instructions specific to this product.
  2. Ask your pharmacist or doctor whether your lot is affected and what to do.

Is yours affected?

Match the list below, then check the codes the FDA notice also names.

Incomplete list: 56 of 66 lot codes shown.

An NDC (National Drug Code) is usually printed on the drug's label.

  1. Corlanor (ivabradine) tablets

    Reason: Presence of Foreign Substance.

    1. Strength
      7.5 mg
      NDC
      • 55513-810-60
      Lot code
      • 1138203
      • 1142065
      • 1145151
      • 1145152
      • 1145153
      • 1148908
      • 1148909
      • 1162845
      • 1162846
      • 1166471
      • 1166472
      • 1166473
      • 1170615
    2. Strength
      5 mg
      NDC
      • 55513-800-99
      • 55513-800-60
      Lot code
      • 1138901
      • 1138201
      • 1138202
      • 1138900
      • 1141143
      • 1149846
      • 1140280
      • 1140281
      • 1142063
      • 1142062
      • 1142942
      • 1142943
      • 1144081
      • 1144104
      • 1146373
      • 1146374
      • 1147491
      • 1147492
      • 1149843
      • 1151113
      • 1151890
      • 1153401
      • 1151114
      • 1151115
      • 1152412
      • 1153399
      • 1153400
      • 1155834
      • 1155835
      • 1155836
      • 1158480
      • 1158481
      • 1158482
      • 1160354
      • 1160355
      • 1161593
      • 1161594
      • 1161595
      • 1164097
      • 1164098
  2. Sensipar (cinacalcet) Tablets

    Reason: CGMP Deviations

    1. Strength
      60 mg
      NDC
      • 55513-074-30
      Lot code
      • 1157055
    2. Strength
      30 mg
      NDC
      • 55513-073-30
      Lot code
      • 1156858
    3. Strength
      90 mg
      NDC
      • 55513-075-30
      Lot code
      • 1157056

From the FDA notice

Corlanor (ivabradine) tablets, 5 mg, packaged in a) 14 tablets bottles (NDC 55513-800-99), and b) 60 tablet bottles (NDC 55513-800-60), Rx Only, Amgen Inc., Thousand Oaks, CA 92130 Made In Italy.

Recall details

Company began the recall
Sold in

Nationwide within the United States

Company
Amgen, Inc.Thousand Oaks, California
Risk

Moderate risk

Taking it may cause short-term health problems, or ones that treatment can reverse. Serious harm is unlikely.

FDA Class II recall · How risk is rated

Event ID
99077
Recall numbers
D-0612-2026 to D-0616-2026

Timeline

FDA's Enforcement Report is its public list of recalls; FDA adds a recall when it posts it and publishes the list weekly.

  1. Company began the recall

  2. Added to FDA's Enforcement Report · Classified by FDA

  3. Listed on Recall Canary

  4. In FDA's weekly enforcement report

  5. Summary updated

Summary by Recall Canary, written with AI · summary updated Oct 10, 2026 · primary source: U.S. Food and Drug Administration (opens in a new tab)